Evidence map›Paper›PMID 31915973›Full record

ArticleGraefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie2020

Assessment of corneal topographic, tomographic, densitometric, and biomechanical properties of Fabry patients with ocular manifestations.

Veysel Cankurtaran, Kemal Tekin, Ayse Idil Cakmak, Merve Inanc, Faruk Hilmi Turgut

Registry-linked trialAbstract read
PubMed Publisher
In one paragraph

Article in Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04752969 (Can Thyroid Levels Affect Topographic, Densitometric and Aberrometric Values of the Cornea), which is not on this map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.5field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04752969 completednot on this map

Can Thyroid Levels Affect Topographic, Densitometric and Aberrometric Values of the Cornea

TypeobservationalSponsorSaglik Bilimleri Universitesi Gazi Yasargil Training and Research HospitalRan2020 to 2021Enrolled60ConditionsThyroid Disorder, Corneal Opacity
3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Ophthalmic Manifestations in Fabry Disease: Updated Review.Journal of personalized medicine · 2023
    Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Veysel CankurtaranOphthalmology Department, Mustafa Kemal University, Antakya, Hatay, Turkey. dr.veyselcankurtaran@hotmail.com.
Kemal TekinOphthalmology Department, Ercis State Hospital, Van, Turkey.
Ayse Idil CakmakOphthalmology Department, Mustafa Kemal University, Antakya, Hatay, Turkey.
Merve InancOphthalmology Department, Ercis State Hospital, Van, Turkey.
Faruk Hilmi TurgutNephrology Department, Mustafa Kemal University, Antakya, Hatay, Turkey.
Mustafa Kemal University · TRSivas State Hospital · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo investigate whether cornea verticillata affects corneal topography, tomography, densitometry, or biomechanics of Fabry patients with ocular manifestations and to compare these results with those obtained from healthy subjects.

methodsThis prospective, cross-sectional study included 23 Fabry patients (Fabry group) with cornea verticillata and the 37 age- and sex-matched healthy subjects (control group). After comprehensive ophthalmological examinations, corneal topography, tomography, and densitometry measurements were taken using Pentacam HR and corneal biomechanics were captured via Corvis ST for all participants.

resultsAll the investigated topographic and tomographic values were similar in the eyes with Fabry disease (FD) and the controls (P > 0.05). The corneal densitometry values of patients with FD were statistically significantly higher in all the concentric zones and layers, except posterior 0-2 mm and posterior 2-6 mm zones, compared to the controls (P < 0.05). The mean values of A1 velocity, A2 velocity, deformation amplitude ratio, Corvis biomechanical index, tomographic and biomechanical index, and Stiffness parameter at the first applanation in the Fabry group were statistically significantly different compared to control group (P < 0.05). However, the mean values of A1 length, A2 length, and the biomechanically corrected intraocular pressure were similar between the groups (P = 0.317, P = 0.819, and P = 0.468; respectively).

conclusionAlthough cornea verticillata associated with FD is not considered to affect vision, it is associated with increased light backscattering and reduced corneal transparency as well as altered corneal biomechanical properties.

Indexed as

AdolescentAdultBiomechanical PhenomenaChildCorneaCorneal DiseasesCorneal PachymetryCorneal TopographyCross-Sectional StudiesDensitometryFabry DiseaseFemaleHumansIntraocular PressureMaleMiddle AgedBiomechanicsCornea verticillataDensitometryFabry diseaseTopography

Identifiers

PMID31915973
OpenAlexW3000003898

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.